Hainan Yedao (Group) Co.,Ltd (SHA:600238)

Revance Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,119	3,424	4,558	7,171	8,148	3,908
Market Cap Growth	-31.21%	-24.88%	-36.44%	-11.99%	108.49%	47.30%
Enterprise Value	3,373	3,691	4,820	7,475	8,403	4,045
Last Close Price	6.96	7.64	10.17	16.00	18.18	8.72
PE Ratio	-	-	-	-	-	160.78
Forward PE	-	18.16	18.16	18.16	18.16	18.16
PS Ratio	18.89	19.54	20.30	17.22	9.78	4.84
PB Ratio	23.62	24.68	16.48	17.38	15.47	6.95
P/TBV Ratio	36.79	37.60	20.24	20.23	19.29	7.38
P/FCF Ratio	-	-	-	-	-	37.29
P/OCF Ratio	-	-	-	-	-	34.27
EV/Sales Ratio	20.42	21.07	21.47	17.95	10.08	5.01
EV/EBITDA Ratio	-	-	-	-	-	68.08
EV/EBIT Ratio	-	-	-	-	-	101.68
EV/FCF Ratio	-126.18	-	-	-	-	38.60
Debt / Equity Ratio	1.74	2.57	1.17	0.75	0.63	0.43
Debt / EBITDA Ratio	-	-	-	-	-	4.04
Debt / FCF Ratio	-	-	-	-	-	2.29
Asset Turnover	0.18	0.18	0.20	0.34	0.68	0.68
Inventory Turnover	0.49	0.53	0.55	0.99	2.47	2.33
Quick Ratio	0.18	0.14	0.24	0.32	0.46	0.68
Current Ratio	0.81	0.81	1.03	0.96	1.27	1.19
Return on Equity (ROE)	-68.16%	-66.27%	-44.56%	-25.48%	-12.02%	4.44%
Return on Assets (ROA)	-5.97%	-5.98%	-3.61%	-7.30%	-4.32%	2.11%
Return on Capital (ROIC)	-12.82%	-10.53%	-6.08%	-11.38%	-6.40%	3.08%
Return on Capital Employed (ROCE)	-	-	-	-	-	6.30%
Earnings Yield	-4.33%	-3.98%	-3.27%	-1.65%	-0.74%	0.62%
FCF Yield	-0.86%	-0.76%	-0.92%	-0.66%	-2.80%	2.68%
Payout Ratio	-	-	-	-	-	68.92%
Buyback Yield / Dilution	-22.57%	-0.40%	0.74%	1.57%	4.84%	-8.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.